China 149022-22-0 Factory

Our mission is to become an innovative supplier of high-tech digital and communication devices by providing value added design, world-class manufacturing, and service capabilities for 149022-22-0,CAS NO 149022-22-0,Amikacin sulfate salt Injection formulation,Amikacin sulfate salt formulation, We hope to establish far more organization associations with consumers all over the globe.
149022-22-0, We welcome an opportunity to do business with you and hope to have pleasure in attaching further details of our products. Excellent quality, competitive price, punctual delivery and dependable service can be guaranteed. For further inquires be sure to do not hesitate to contact us.

Hot Products

  • Lurasidone hydrochloride

    Lurasidone hydrochloride

    Product Name:Lurasidone hydrochloride
    Molecular Formula:C28H37ClN4O2S
    Molecular Weight;529.14
    CAS Registry Number;367514-88-3
  • 1-Boc-3-piperidone

    1-Boc-3-piperidone

    Product Name:1-Boc-3-piperidone
    Molecular Formula:C10H17NO3
    Molecular Weight:199.25
    CAS Registry Number:98977-36-7
  • Glycidyl methacrylate

    Glycidyl methacrylate

    Product Name:Glycidyl methacrylate
    Molecular Formula:C7H10O3
    Molecular Weight:142.15
    CAS Registry Number:106-91-2
  • Nadifloxacin

    Nadifloxacin

    Product Name:Nadifloxacin
    Molecular Formula:C19H21FN2O4
    Molecular Weight;360.38
    CAS Registry Number;124858-35-1
  • (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

    (4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

    Product Name:(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
    Molecular Formula:C14H23NO4
    Molecular Weight:269.34
    CAS Registry Number:125971-94-0
  • Latanoprost

    Latanoprost

    Product Name:Latanoprost
    Molecular Formula:C26H40O5
    Molecular Weight:432.59
    CAS Registry Number:130209-82-4

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept